Jake Hernandez

Jake specialises in preparing for and responding to situations that are beyond an organisation’s control: this includes everything from pandemics, to cyber breaches, to kidnap. He is an internationally recognised political and security risk and crisis management consultant, having worked in some of the world’s most difficult jurisdictions – including Iraq, Yemen, Pakistan, Syria and Ukraine – and previously leading complex corporate resilience, crisis management and market entry advisory projects at consulting firm Control Risks. He began his career working and living in Yemen working for a range of local organisations, and witnessed first-hand how extreme circumstances can affect individuals and organisations.

‍

Jake was subsequently accepted into the renowned Department of War Studies at King’s College, London to study international conflict and political upheaval in the Middle East and South Asia; this included an invitation to the University of Karachi as a counterterrorism guest lecturer. He has supported some of the world’s largest corporations and organisations –from the largest oil and gas company on the planet, to complex critical national infrastructure projects of strategic significance, to some of the world’s most exclusive hotel chains – in some of the world’s most difficult environments and through some of their most difficult security and resilience challenges. Jake was one of the youngest senior consultants ever in a major political and security risk consulting firm and was also a non-executive director in geospatial technology start-up, Gryd. Jake is also a fluent Arabic speaker.

‍

More recently, Jake has been supporting large clients and Lloyd’s of London insurance brokers and underwriters in dealing with the fall-out of the COVID-19 pandemic, an expansion in ransomware attacks in 2021, the Russo-Ukrainian War, and mounting tensions and conflicts in the Middle East. Jake has also worked on assessing risks for IPOs and de-SPAC transactions into public markets amounting to over $20 billion, and advising global technology and pharmaceutical clients on their distributed risk exposures across both physical risk and cyber.